Chonluten
$66.99
This material is supplied solely as a laboratory research article. Buyer is responsible for ensuring lawful purchase, handling, storage, and use. We do not provide administration or therapeutic guidance.
Quality Certificates
Independent third-party lab analysis (CoA) - from our own in-house brand.
Chonluten - Synthetic Tripeptide (Glu-Asp-Gly), Research Reference Material
FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.

Analytical Identity
| Common name | Chonluten |
|---|---|
| Amino-acid sequence | EDG |
| Sequence (3-letter) | Glu-Asp-Gly |
| Residues | 3 |
| Molecular formula | C11H18N4O8 |
|---|---|
| Molecular weight | 334.3 g/mol |
| Appearance | White to off-white lyophilized powder |
| Physical form | Lyophilized powder |
| Purity | Not less than 98% by HPLC (see lot-specific Certificate of Analysis) |
|---|---|
| Source | Synthetic |
| Catalog / SKU | CHONLUTEN |
Chonluten is supplied as a laboratory research reference material intended solely for in-vitro and laboratory research use. This synthetic tripeptide corresponds to the primary sequence Glu-Asp-Gly (EDG, three residues, three-letter notation Glu-Asp-Gly), assembled from two acidic residues followed by a terminal glycine. The confirmed molecular formula is C11H18N4O8 with a monoisotopic-consistent average molecular weight of 334.3 g/mol, reflecting the free N-terminal alpha-amino group, the free C-terminal carboxyl, and the pendant gamma- and beta-carboxylic acid side chains contributed by glutamic acid and aspartic acid respectively.
Chonluten is presented as a white to off-white lyophilized powder produced by solid-phase peptide synthesis. The material contains four nitrogen atoms and eight oxygen atoms distributed across three amide/peptide-relevant environments and multiple carboxyl functionalities, giving it a strongly acidic character in aqueous reconstitution studies and a relatively polar, hydrophilic profile useful as a low-molecular-weight peptide reference. Analytical workflows typically leverage these features for reversed-phase HPLC retention benchmarking, UV response characterization at low wavelengths, and mass-spectrometric identity confirmation against the expected 334.3 g/mol average mass.
Published scientific literature has examined Chonluten (Glu-Asp-Gly, EDG) in preclinical research settings, and this catalog entry (SKU: CHONLUTEN) is offered strictly to support such laboratory investigations, method development, analytical qualification, and comparative peptide chemistry work. PEPTIDE.Power makes no therapeutic, diagnostic, or efficacy claims regarding this material and provides no administration or dosing guidance of any kind.
Identity, sequence fidelity, and chromatographic purity of not less than 98% by HPLC are documented on the lot-specific Certificate of Analysis, available on request, which serves as the authoritative record for each batch of Chonluten released. This material is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion.
Physical format
Supplied as a lyophilized (freeze-dried) powder in a sealed vial. A research reference material - not a finished product and not a delivery device. Net contents per unit are shown in the product options.
Certificate of Analysis
| Issuing laboratory | Analiza Białek |
|---|---|
| Analyte | Chonluten |
| CAS Number | - |
| Lot / Batch | K12PP |
| Appearance | White to off-white lyophilized powder |
| Purity (HPLC) | 99% |
| Identity | Confirmed by HPLC and mass spectrometry |
Lot-specific COA available — contact [email protected] with your lot number.
Storage & handling
Store the sealed lyophilized powder at -20 C, protected from light and moisture. After reconstitution for laboratory use, keep cold and use promptly. Handle per standard laboratory practice; a Safety Data Sheet (SDS) is available on request.
Scientific references
The following are independent, peer-reviewed publications provided for reference. They describe third-party research and are not representations by POWER BIOTECH LLC regarding this product.
- Peptidergic regulation of expression of genes encoding antioxidant and proapoptotic proteins in bronchial epithelium — https://pubmed.ncbi.nlm.nih.gov/19370905/
- Khavinson peptides regulate gene expression and protein synthesis: cellular and molecular mechanisms — https://pubmed.ncbi.nlm.nih.gov/22645890/
- Short Peptides and Telomere Length Regulator Hormone Irisin — https://pmc.ncbi.nlm.nih.gov/articles/PMC7232050/
- Peptide regulation of cell differentiation — https://pubmed.ncbi.nlm.nih.gov/24527600/
- Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation and renewal — https://pubmed.ncbi.nlm.nih.gov/23330305/
- Effects of peptide bioregulators on bronchopulmonary system function — https://pubmed.ncbi.nlm.nih.gov/29797287/
Eligibility & terms of sale
This material is sold to qualified laboratory and research buyers for lawful research use only. It is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. By purchasing, you confirm you are 21 or older and will use this material only for lawful laboratory research.
FAQ
What is the purity and how is it verified?
Not less than 98% by HPLC; see the Certificate of Analysis for the lot-specific result.
What form does it ship in?
A lyophilized powder in a sealed vial.
Can you advise on dosing, reconstitution, or administration?
No. We provide batch documentation, storage, and handling information only; we do not provide dosing, reconstitution, administration, or therapeutic guidance.
Is lot-specific documentation available?
Yes - contact [email protected] with your lot number for the Certificate of Analysis.
Related reference materials
Sold by POWER BIOTECH LLC, Casper, WY 82609, United States · [email protected]. FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.
